Nine Months
Ended September 30,
|
Increase
(decrease)
|
|||||||||||||||
2019 | 2018 | $ | % | |||||||||||||
Commissions
|
$
|
4,207
|
$
|
3,844
|
$
|
363
|
9.4
|
%
|
||||||||
Hard dollar payments
|
343
|
588
|
(245
|
)
|
-41.7
|
%
|
||||||||||
4,550
|
4,432
|
$
|
118
|
2.7
|
%
|
|||||||||||
Research services
|
1,128
|
1,649
|
(521
|
)
|
-31.6
|
%
|
||||||||||
Underwriting fees
|
75
|
19
|
56
|
294.7
|
%
|
|||||||||||
Sales manager fees
|
590
|
100
|
490
|
490.0
|
%
|
|||||||||||
Total
|
$
|
6,343
|
$
|
6,200
|
$
|
143
|
2.3
|
%
|
Nine Months Ended
September 30,
|
||||||||
2019
|
2018
|
|||||||
Cash flows provided by (used in):
|
||||||||
Operating activities
|
$
|
(2,507
|
)
|
$
|
(3,330
|
)
|
||
Investing activities
|
-
|
(60
|
)
|
|||||
Financing activities
|
(3,300
|
)
|
-
|
|||||
Net decrease in cash and cash equivalents
|
(5,807
|
)
|
(3,390
|
)
|
||||
Cash and cash equivalents and restricted cash at beginning of year
|
11,401
|
11,640
|
||||||
Cash and cash equivalents and restricted cash at end of year
|
$
|
5,594
|
$
|
8,250
|